Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Codexis

November 2025

Codexis Market Share Analysis for November 2025

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Year Founded2002
Employees51 - 200
Annual Revenue$100M - $200M
codexis.com
Codexis
Codexis (including company regionals)
  • codexis.com
    codexis.com
See more website traffic and engagement information

Codexis Revenue up to November 2025 is 100M - 200M

revenue generated by Codexis top domains

Codexis top domains revenue over 3 years

Revenue for Codexis top domains

codexis.comcodexis.com100M - 200M
See more with Sales Intelligence

Total visits to Codexis's top domains

Understand Codexis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Codexis's top domains

Analyze Codexis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Codexis's top domains

See how Codexis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Codexis

These are the website technologies, by industry, used by Codexis top domains

Advertising (16)

DoubleClick

DoubleClick

Widget (4)

reCAPTCHA

reCAPTCHA

Audio Video Media (3)

YouTube

YouTube

Content Management System (3)

WordPress

WordPress

More Technologies

12

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Codexis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCodexis, Inc. integrates with Nitto Denko Avecia Inc..By combining Codexis' innovative ECO Synthesis(R) Manufacturing Platform with Nitto Denko Avecia's expertise in manufacturing oligonucleotide therapeutics at scale, this collaboration marks a pivotal step toward advancing scalable and sustainable therapeutic siRNA manufacturing.
NewsCodexis, Inc. sells assets to Crosswalktherapeutics.In a strategic move to advance these therapies, Crosswalk Therapeutics acquired investigational Fabry disease compounds from Codexis.
NewsCodexis, Inc. attends event 2025 Annual Meeting of Stockholders.Codexis (NASDAQ: CDXS) announced that Byron Dorgan will retire from its Board of Directors at the 2025 Annual Meeting of Stockholders.

See all Codexis signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.